Back to Search Start Over

Bovine Lactoferrin Induces Cell Death in Human Prostate Cancer Cells.

Authors :
Rocha VP
Campos SPC
Barros CA
Trindade P
Souza LRQ
Silva TG
Gimba ERP
Teodoro AJ
Gonçalves RB
Source :
Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2022 Sep 02; Vol. 2022, pp. 2187696. Date of Electronic Publication: 2022 Sep 02 (Print Publication: 2022).
Publication Year :
2022

Abstract

Bovine lactoferrin (bLf) is a multifunctional protein widely associated with anticancer activity. Prostate cancer is the second most frequent type of cancer worldwide. This study was aimed at evaluating the influence of bLf on cell viability, cell cycle progression, reactive oxygen species (ROS) production, and rate of apoptosis in the human prostate cancer cell line (DU-145). MTT assay and trypan blue exclusion were used to analyze cell viability. Morphological changes were analyzed through optical microscopy after 24 h and 48 h of bLf treatment. FITC-bLf internalization and cellular damage were observed within 24 h by confocal fluorescence microscopy. Cell cycle analyses were performed by flow cytometry and propidium iodide. For caspases 3/7 activation and reactive oxygen species production evaluation, cells were live-imaged using the high-throughput system Operetta. The cell viability assays demonstrated that bLf induces cell death and morphological changes after 24 h and 48 h of treatment compared to control on DU-145 cells. The bLf internalization was detected in DU-145 cells, G <subscript>1</subscript> -phase arrest of the cell cycle, caspase 3/7 activation, and increased oxidative stress on bLf-treated cells. Our data support that bLf has an important anticancer activity, thus offering new perspectives in preventing and treating prostate cancer.<br />Competing Interests: The authors declare that there is no conflict of interest regarding the publication of this paper.<br /> (Copyright © 2022 Vanessa P. Rocha et al.)

Details

Language :
English
ISSN :
1942-0994
Volume :
2022
Database :
MEDLINE
Journal :
Oxidative medicine and cellular longevity
Publication Type :
Academic Journal
Accession number :
36092155
Full Text :
https://doi.org/10.1155/2022/2187696